MAM
Honda unveils brand strategy for ‘Dream’ series in India
MUMBAI: After splitting from its local joint venture partner Hero, Honda Motorcycle and Scooter India (HMSI) launched its India specific three-pronged corporate direction.
Honda‘s brand slogan in India ‘Sach Kar Denge Sapne‘ is inspired by the global brand slogan ‘Power of Dreams’. It aims to connect emotionally with customers of all demographics and psychographics by associating with brand ambassador Akshay Kumar and to create a new benchmark with Dream Yuga – Honda‘s foray into the mass motorcycle segment.
The slogan recognises India as the centre of the global two-wheeler business for the coming times, and expresses Honda‘s future vision: to share “our dreams with others and make them a reality”.
The company said Bollywood actor Kumar has both emotionally touched and rationally inspired a generation of young Indians to become achievers and, hence, captures the essence of brand Honda.
Honda‘s first mass motorcycle, Dream D, was launched in 1949 by founder Soichiro. Since then, Honda has launched a series of successful ‘Dream‘ models globally. With a legacy of over 50 years, Honda has now launched the legendary Dream series in India. With Dream Yuga launched, Honda has taken its first big step towards mass mobility in India.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
